# INLYTA

NDC: 0069-0151
Generic name: axitinib
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20120127

FDA application: NDA202324

## Active ingredients

- AXITINIB: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0151"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0151
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=84137882-e000-47da-bd5b-fa76ab3c76f9